Stay updated on Clinical Trial: Benfotiamine in Alzheimer's Disease
Sign up to get notified when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.

Latest updates to the Clinical Trial: Benfotiamine in Alzheimer's Disease page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new link to the Genetic and Rare Diseases Information Center was added under Resources and 'Amyloidosis' was added as a keyword, while the page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check20 days agoChange DetectedRevision: v3.4.1 replaces the previous v3.4.0 on the page. The update appears to be a minor backend/markup revision without changes to study details or user-visible content.SummaryDifference0.1%

- Check27 days agoChange DetectedShow glossary toggle added; QC-related labels updated for capitalization; and revision text updated from v3.3.4 to v3.4.0. These changes are cosmetic metadata updates and do not modify the core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision has been updated to v3.3.4. The previous revision was v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section updated to include New York as a study site (White Plains, NY). Revision: v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedTwo minor textual updates were made: a note about publications being provided voluntarily and a revision tag (Revision: v3.3.2) were added, which do not affect core study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Benfotiamine in Alzheimer's Disease
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.